Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity

by Diego A.S. Toesca, MD, Amanda J. Koong, Rie von Eyben, MSc, Albert C. Koong, MD, PhD, Daniel T. Chang, MD
Published 2018-10-01

The role of bone marrow and spleen irradiation in the development of acute hematologic toxicity during chemoradiation for esophageal cancer

by Alexander L. Chin, MD, MBA, Sonya Aggarwal, BS, Pooja Pradhan, BS, Karl Bush, PhD, Rie von Eyben, MS, Albert C. Koong, MD, PhD, Daniel T. Chang, MD
Published 2018-07-01

Dose escalation for locally advanced pancreatic cancer: How high can we go?

by Lauren E. Colbert, MD, Neal Rebueno, CMD, Shalini Moningi, MD, Sam Beddar, PhD, Gabriel O. Sawakuchi, PhD, Joseph M. Herman, MD, Albert C. Koong, MD, PhD, Prajnan Das, MD, Emma B. Holliday, MD, Eugene J. Koay, MD, PhD, Cullen M. Taniguchi, MD, PhD
Published 2018-10-01

IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer

by Shalini Moningi, MD, Jaffer A. Ajani, MD, Brian D. Badgwell, MD, Mariela B. Murphy, MD, Naruhiko Ikoma, MD, Paul F. Mansfield, MD, Jennifer C. Ho, MD, Yelin Suh, BS, Christopher Crane, MD, Joseph M. Herman, MD, Emma B. Holliday, MD, Eugene Koay, MD, PhD, Albert C. Koong, MD, PhD, Sunil Krishnan, MD, Bruce Minsky, MD, Grace Smith, MD, Cullen Taniguchi, MD, PhD, Prajnan Das, MD
Published 2020-05-01

Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era

by Joseph Abi Jaoude, MD, Connor P. Thunshelle, BS, Ramez Kouzy, MD, Nicholas D. Nguyen, BA, Daniel Lin, BA, Laura Prakash, MD, Isabela M. Bumanlag, BS, Sonal S. Noticewala, MD, Joshua S. Niedzielski, PhD, Sam Beddar, PhD, Ethan B. Ludmir, MD, Emma B. Holliday, MD, Prajnan Das, MD, MS, MPH, Bruce D. Minsky, MD, Joseph M. Herman, MD, Matthew Katz, MD, Albert C. Koong, MD, PhD, Eugene J. Koay, MD, PhD, Cullen M. Taniguchi, MD, PhD
Published 2021-11-01

Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer

by Shalini Moningi, MD, Joseph Abi Jaoude, MD, Ramez Kouzy, MD, Daniel Lin, BA, Nicholas D. Nguyen, BA, Carolina J. Garcia Garcia, BS, Jae L. Phan, BA, Santiago Avila, BA, Daniel Smani, BA, Irina M. Cazacu, MD, Ben S. Singh, BA, Grace L. Smith, MD, PhD, MPH, Emma B. Holliday, MD, Eugene J. Koay, MD, PhD, Prajnan Das, MD, MS, MPH, Manoop S. Bhutani, MD, Joseph M. Herman, MD, MSc, MSHM, Bruce D. Minsky, MD, Albert C. Koong, MD, PhD, Cullen M. Taniguchi, MD, PhD
Published 2021-03-01